Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE

Neuroscience Letters

Volumn 250, Issue 3, 1998, Pages 189-192

  Song, Y Q ^a,b   Rogaeva, E ^a,b   Premkumar, S ^c   Brindle, N ^a,b   Kawarai, T ^a,b   Orlacchio, An ^a,b   Yu, G ^a,b   Levesque, G ^a,b   Nishimura, M ^a,b   Ikeda, M ^a,b   Pei, Y ^a,b   O'Toole, C ^a,b   Duara, R ^d   Barker, W ^d   Sorbi, S ^e   Freedman, M ^f   Farrer, L ^c   St George Hyslop, P ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Wien Ctr Mt Sinai Med C   (United States)

^e UNIVERSITY OF FLORENCE   (Italy)

^f BAYCREST CENTRE FOR GERIATRIC CARE   (Canada)

Author keywords

491 A T polymorphism; Alzheimer disease; APOE 2 3 4 polymorphism

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; GENE FREQUENCY; HUMANS; POLYMORPHISM, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 0032503943     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00470-4     Document Type: Article

References (7)

1. Breslow, N.E. and Day, N.E., The analysis of case control studies: statistical methods in cancer research, Vol. 1, IARC Scientific Publications 32, Lyon, 1980.
2. Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldulo J., Lendon C., Han S.W., Morris J.C., Frank A., Vasquez J., Goate A., Valdivieso F. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's Disease. Nat. Genet. 18:1998;69-71.
3. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's Disease: a meta-analysis (APOE and Alzheimer's Disease Meta Analysis consortium). J. Am. Med. Assoc. 278:1997;1349-1356.
4. Khachaturian Z.S. Diagnosis of Alzheimer Disease. Arch. Neurol. 42:1985;1097-1105.
5. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer Disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Dept. of Health and Human Services Task force on Alzheimer Disease. Neurology. 34:1984;939-944.
6. SAS User's guide: Statistics. SAS Institute, Cary, NC, 1992.
7. Saunders A., Strittmatter W.J., Schmechel S., St. George-Hyslop P., Pericak-Vance M., Joo S.H., Rosi B.L., Gusella J.F., Crapper-McLachlan D., Growden J., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apoliprotein E allele e4 with the late-onset familial and sporadic Alzheimer Disease. Neurology. 43:1993;1467-1472.